CVS Health’s iShares 5-10 Year Investment Grade Corporate Bond ETF IGIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.4M Buy
440,000
+347,250
+374% +$18.5M 10.39% 2
2026
Q1
$4.94M Hold
92,750
– – 2.33% 14
2025
Q4
$5M Buy
+92,750
New +$5.01M 3.69% 3

Other funds holding IGIB

CVS Health's IGIB Position: Q2 2026 in Review

CVS Health increased its iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) stake by 374% in Q2 2026, buying an estimated $18.5M and bringing the position to 440,000 shares worth $23.4M. The position accounts for 10.39% of the portfolio, ranked #2.

CVS Health first reported a position in IGIB in Q4 2025 and has held it in 3 quarters since. 712 funds tracked by Wall St. Rank hold IGIB as of Q2 2026.

  • CVS Health held 440,000 shares of iShares 5-10 Year Investment Grade Corporate Bond ETF worth $23.4M as of Q2 2026.
  • CVS Health bought 347,250 iShares 5-10 Year Investment Grade Corporate Bond ETF shares in Q2 2026, an estimated $18.5M.
  • iShares 5-10 Year Investment Grade Corporate Bond ETF made up 10.39% of CVS Health's portfolio in Q2 2026, its #2 holding.
  • CVS Health first reported a position in iShares 5-10 Year Investment Grade Corporate Bond ETF in Q4 2025 and has held it in 3 quarters since.
  • 712 funds tracked by Wall St. Rank held iShares 5-10 Year Investment Grade Corporate Bond ETF as of Q2 2026.

Based on CVS Health's 13F filing for Q2 2026, filed 6 Aug 2026.